徳島大学 教育・研究者情報データベース(EDB)

1. 數藤 久美子

   役割	任意
   貢献度	任意
   学籍番号	推奨

2. 福田 大受

   役割	任意
   貢献度	任意
   学籍番号	推奨

3. (英) Shinohara Masakazu

   役割	任意
   貢献度	任意
   学籍番号	推奨

4. (英) Ganbaatar Byambasuren / (日) GANBAATAR BYAMBASUREN / (読) がんばとる びやんばすれん

   役割	任意
   貢献度	任意
   学籍番号	推奨	****

5. 八木 秀介([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.内科系.地域・家庭医療学])

   役割	任意
   貢献度	任意
   学籍番号	推奨

6. 楠瀬 賢也

   役割	任意
   貢献度	任意
   学籍番号	推奨

7. 山田 博胤([徳島大学.大学院医歯薬学研究部.医学域.連携研究部門(医学域).寄附講座系(医学域).地域循環器内科学])

   役割	任意
   貢献度	任意
   学籍番号	推奨

8. 添木 武([徳島大学.大学院医歯薬学研究部.医学域.連携研究部門(医学域).寄附講座系(医学域).実践地域診療・医科学])

   役割	任意
   貢献度	任意
   学籍番号	推奨

9. (英) Hirata Ken-Ichi

   役割	任意
   貢献度	任意
   学籍番号	推奨

10. 佐田 政隆([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.内科系.循環器内科学])

    役割	任意
    貢献度	任意
    学籍番号	推奨

(英) Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice.

(英) Various pathological processes related to diabetes cause endothelial dysfunction. Eicosanoids derived from arachidonic acid (AA) have roles in vascular regulation. Fibrates have recently been shown to attenuate vascular complications in diabetics. Here we examined the effects of pemafibrate, a selective peroxisome proliferator-activated receptor α modulator, on plasma eicosanoid levels and endothelial function in diabetic mice. Diabetes was induced in 7-week-old male wild-type mice by a single injection of streptozotocin (150 mg/kg). Pemafibrate (0.3 mg/kg/day) was administered orally for 3 weeks. Untreated mice received vehicle. Circulating levels of eicosanoids and free fatty acids were measured using both gas and liquid chromatography-mass spectrometry. Endothelium-dependent and endothelium-independent vascular responses to acetylcholine and sodium nitroprusside, respectively, were analyzed. Pemafibrate reduced both triglyceride and non-high-density lipoprotein -cholesterol levels (P<0.01), without affecting body weight. It also decreased circulating levels of AA (P<0.001), thromboxane B (P<0.001), prostaglandin E, leukotriene B (P<0.05), and 5-hydroxyeicosatetraenoic acid (P<0.001), all of which were elevated by the induction of diabetes. In contrast, the plasma levels of 15-deoxy-Δ-prostaglandin J, which declined following diabetes induction, remained unaffected by pemafibrate treatment. In diabetic mice, pemafibrate decreased palmitic acid (PA) and stearic acid concentrations (P<0.05). Diabetes induction impaired endothelial function, whereas pemafibrate ameliorated it (P<0.001). The results of ex vivo experiments indicated that eicosanoids or PA impaired endothelial function. Pemafibrate diminished the levels of vasoconstrictive eicosanoids and free fatty acids accompanied by a reduction of triglyceride. These effects may be associated with the improvement of endothelial function by pemafibrate in diabetic mice.

1. (英) Article.ELocationID: 10.5551/jat.61101

2. (英) Article.PublicationTypeList.PublicationType: Journal Article

3. (英) KeywordList.Keyword: Diabetes

4. (英) KeywordList.Keyword: Eicosanoid

5. (英) KeywordList.Keyword: Endothelial function

6. (英) KeywordList.Keyword: Pemafibrate